ClinConnect ClinConnect Logo
Search / Trial NCT06011720

Transitions of Care for Stroke Patients

Launched by KIWON LEE MD · Aug 23, 2023

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

Stroke Physiatry Rehabilitation Pm&R Consultation Transient Ischemic Attack Intracerebral Hemorrhage Ischemic Stroke

ClinConnect Summary

This clinical trial, called "Transitions of Care for Stroke Patients," is looking to improve how stroke patients recover after they leave the hospital. Researchers believe that starting rehabilitation right after a stroke can help patients regain their abilities and reduce the negative effects of being inactive. The trial is specifically testing whether better coordination between medical teams and rehabilitation specialists can lead to better recovery and follow-up care for these patients.

To participate in this study, individuals must be hospitalized at Robert Wood Johnson University Hospital for either Ischemic Stroke (a type of stroke caused by a blockage in a blood vessel) or Intracerebral Hemorrhage (a type of stroke caused by bleeding in the brain). Unfortunately, patients with certain other conditions, such as a Subarachnoid Hemorrhage (bleeding in the area between the brain and the tissues covering it) or those who have had a Transient Ischemic Attack (a temporary stroke-like event), are not eligible. If someone qualifies and joins the trial, they can expect to receive personalized care aimed at improving their recovery journey.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Stroke patients hospitalized within Robert Wood Johnson University Hospital system for Ischemic Stroke or Intracerebral Hemorrhage.
  • Exclusion Criteria:
  • Those not in the Robert Wood Johnson University Hospital system.
  • Those with a Subarachnoid Hemorrhage or Transient Ischemic Attack (\< 24 hours).

About Kiwon Lee Md

Kiwon Lee, MD, is a distinguished clinical trial sponsor known for his commitment to advancing medical research and improving patient outcomes. With a robust background in clinical medicine and a focus on innovative therapeutic approaches, Dr. Lee leads initiatives aimed at evaluating new treatments across various medical disciplines. His expertise in trial design and execution ensures rigorous adherence to regulatory standards while fostering collaboration among multidisciplinary teams. Through his dedication to evidence-based practice, Dr. Lee strives to contribute to the development of groundbreaking therapies that enhance healthcare delivery and patient quality of life.

Locations

New Brunswick, New Jersey, United States

Patients applied

0 patients applied

Trial Officials

Kiwon Lee, MD

Principal Investigator

Rutgers, The State University of New Jersey

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported